Sana Biotechnology Inc (SANA) — Cash Flow-to-Debt Ratio
Sana Biotechnology Inc (SANA) has a Cash Flow-to-Debt Ratio of -0.13x as of December 2025, meaning its operating cash flow of $-32.64 Million could theoretically repay 0% of its total liabilities ($256.01 Million) in one year. See Sana Biotechnology Inc (SANA) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sana Biotechnology Inc Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Sana Biotechnology Inc across 8 annual periods. Also explore Sana Biotechnology Inc equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Sana Biotechnology Inc (2018–2025)
Year-by-year debt coverage analysis for Sana Biotechnology Inc. For market capitalisation and broader financial context, see Sana Biotechnology Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.56x | $-143.83 Million | $256.01 Million | ▲ +36.9% |
| 2024 | -0.89x | $-223.15 Million | $250.52 Million | ▲ +2.4% |
| 2023 | -0.91x | $-253.58 Million | $277.79 Million | ▼ -1.8% |
| 2022 | -0.90x | $-290.05 Million | $323.40 Million | ▼ -43.2% |
| 2021 | -0.63x | $-251.05 Million | $400.90 Million | ▼ -422.6% |
| 2020 | -0.12x | $-137.98 Million | $1.15 Billion | ▲ +21.8% |
| 2019 | -0.15x | $-85.50 Million | $557.73 Million | ▲ +46.0% |
| 2018 | -0.28x | $-13.49 Million | $47.52 Million | — |